CBS meets its targets, there is no shortage. The private plasma folks are collecting and exporting to world market. They are not licenced to manufacture or distribute in Canada.  The paid donation is passed onto the manufacturer and the end consumer on the world market. CBS exports 17% of its surplus plasma for manufacturing of plasma related material and gets 100% of it back. They have to as there is no Canadian company yet to produce the finished pharmaceutical plasma product.   CBS mandate is to insure domestic supply in the demand of patient need. Canada cannot be held hostage by private profit entities in this area. It makes sense that CBS get a head of the trend.